Myocardial Bridge: Harmless or Harmful
نویسندگان
چکیده
منابع مشابه
Nesiritide: harmful or harmless?
Nesiritide is the recombinant form of human B-type (brain) natriuretic peptide (BNP), and its amino acid sequence is identical to that of endogenous human BNP. Administration of nesiritide results in venous and arterial vasodilation, as well as enhanced diuresis. Given the many limitations of therapies previously available for the treatment of acute decompensated heart failure, the anticipation...
متن کاملDietary arachidonic acid: harmful, harmless or helpful?
Mammalian cells and tissues contain substantial amounts of the n-6 PUFA arachidonic acid, especially in their membrane phospholipids. For example, platelets from human adults living on a typical Western diet have about 25% phospholipid fatty acids as arachidonic acid, while for human mononuclear cells, neutrophils, erythrocytes, skeletal muscle, cardiac tissue and liver phospholipids, arachidon...
متن کاملHarmful devices considered harmless
Attacks on host computers by malicious peripherals are a growing problem; the inexorable advance of powerful, small, cheap peripherals, which attach to plug-and-play buses, has made such attacks easy to mount. At the same time, commodity operating systems lack systematic defenses. We present Cinch, a pragmatic response to this threat. Cinch transforms USB peripherals to untrusted network endpoi...
متن کاملMyocardial bridge, surgery or stenting?
This report reviews the clinical experience of surgical treatment and stent implantation for myocardial bridge over the past 7 years at Fu Wai Hospital. Operations were performed on 15 patients for myocardial bridge. There were 10 male and 5 female patients aged from 35 to 67 years (mean age, 49.2 years). Nine of them were associated with other cardiac diseases and the remaining six were MB onl...
متن کاملBreast cancer gene variants: separating the harmful from the harmless.
Individuals carrying a mutation in the breast cancer 1, early onset gene (BRCA1) are at increased risk of breast or ovarian cancer and thus are candidates for risk reduction strategies such as oophorectomy and mastectomy. A recurring problem in the clinic is that many detectable changes within the BRCA1 gene produce subtle alterations to the protein that are not easily recognized as either harm...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Internal Medicine
سال: 2004
ISSN: 0918-2918,1349-7235
DOI: 10.2169/internalmedicine.43.1097